EGFR and non-small cell lung carcinoma: Cobas plasma EGFR mutation test v2 can identify multiple mutations in exons 18, 19, 20, and 21 of EGFR in NSCLC patients, including exon 19 deletion, and L858R, G719X, S768I, L861Q, and T790M substitution.